Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Richard Kettmann is active.

Publication


Featured researches published by Richard Kettmann.


Retrovirology | 2008

The HTLV-1 Tax interactome.

Mathieu Boxus; Jean-Claude Twizere; Sébastien Legros; Jean François Dewulf; Richard Kettmann; Luc Willems

The Tax1 oncoprotein encoded by Human T-lymphotropic virus type I is a major determinant of viral persistence and pathogenesis. Tax1 affects a wide variety of cellular signalling pathways leading to transcriptional activation, proliferation and ultimately transformation. To carry out these functions, Tax1 interacts with and modulates activity of a number of cellular proteins. In this review, we summarize the present knowledge of the Tax1 interactome and propose a rationale for the broad range of cellular proteins identified so far.


Retrovirology | 2007

Mechanisms of leukemogenesis induced by bovine leukemia virus: prospects for novel anti-retroviral therapies in human

Nicolas Gillet; Arnaud-Francois Florins; Mathieu Boxus; Catherine Burteau; Annamaria Nigro; Fabian Vandermeers; Herve Balon; Amel Bouzar; Julien Defoiche; Arsène Burny; Michal Reichert; Richard Kettmann; Luc Willems

In 1871, the observation of yellowish nodules in the enlarged spleen of a cow was considered to be the first reported case of bovine leukemia. The etiological agent of this lymphoproliferative disease, bovine leukemia virus (BLV), belongs to the deltaretrovirus genus which also includes the related human T-lymphotropic virus type 1 (HTLV-1). This review summarizes current knowledge of this viral system, which is important as a model for leukemogenesis. Recently, the BLV model has also cast light onto novel prospects for therapies of HTLV induced diseases, for which no satisfactory treatment exists so far.


Oncogene | 2007

Class IIa histone deacetylases: regulating the regulators

Maud Martin; Richard Kettmann; Franck Dequiedt

In the last decade, the identification of enzymes that regulate acetylation of histones and nonhistone proteins has revealed the key role of dynamic acetylation and deacetylation in various cellular processes. Mammalian histone deacetylases (HDACs), which catalyse the removal of acetyl groups from lysine residues, are grouped into three classes, on the basis of similarity to yeast counterparts. An abundance of experimental evidence has established class IIa HDACs as crucial transcriptional regulators of various developmental and differentiation processes. In the past 5 years, a tremendous effort has been dedicated to characterizing the regulation of these enzymes. In this review, we summarize the latest discoveries in the field and discuss the molecular and structural determinants of class IIa HDACs regulation. Finally, we emphasize that comprehension of the mechanisms underlying class IIa HDAC functions is essential for potential therapeutic applications.


Journal of Experimental Medicine | 2005

Phosphorylation of histone deacetylase 7 by protein kinase D mediates T cell receptor–induced Nur77 expression and apoptosis

Franck Dequiedt; Johan Van Lint; Emily Lecomte; Viktor Van Duppen; Thomas Seufferlein; Jackie R. Vandenheede; Ruddy Wattiez; Richard Kettmann

The molecular basis of thymocyte negative selection, a crucial mechanism in establishing central tolerance, is not yet resolved. Histone deacetylases (HDACs) have emerged as key transcriptional regulators in several major developmental programs. Recently, we showed that the class IIa member, HDAC7, regulates negative selection by repressing expression of Nur77, an orphan nuclear receptor involved in antigen-induced apoptosis of thymocytes. Engagement of the T cell receptor (TCR) alleviates this repression through phosphorylation-dependent nuclear exclusion of HDAC7. However, the identity of the TCR-activated kinase that phosphorylates and inactivates HDAC7 was still unknown. Here, we demonstrate that TCR-induced nuclear export of HDAC7 and Nur77 expression is mediated by activation of protein kinase D (PKD). Indeed, active PKD stimulates HDAC7 nuclear export and Nur77 expression. In contrast, inhibition of PKD prevents TCR-mediated nuclear exclusion of HDAC7 and associated Nur77 activation. Furthermore, we show that HDAC7 is an interaction partner and a substrate for PKD. We identify four serine residues in the NH2 terminus of HDAC7 as targets for PKD. More importantly, a mutant of HDAC7 specifically deficient in phosphorylation by PKD, inhibits TCR-mediated apoptosis of T cell hybridomas. These findings indicate that PKD is likely to play a key role in the signaling pathways controlling negative selection.


Plant Physiology | 1993

A Calcium/Calmodulin-Binding Serine/Threonine Protein Kinase Homologous to the Mammalian Type II Calcium/Calmodulin-Dependent Protein Kinase Is Expressed in Plant Cells

Bernard Watillon; Richard Kettmann; Philippe Boxus; Arsène Burny

cDNA fragments corresponding to an apple (Malus domestica [L.] Borkh) calmodulin-binding polypeptide have been isolated and characterized. The protein encoded by this messenger contains a serine/threonine protein kinase catalytic domain followed by a calcium/calmodulin-binding regulatory domain, both exhibiting significant sequence similarities to the corresponding regions of the mammalian calcium/calmodulin-dependent protein kinase II subunits. These results confirm a potential regulatory role for calmodulin in phosphorylation-mediated signal transduction events.


The EMBO Journal | 1990

Cooperation between bovine leukaemia virus transactivator protein and Ha-ras oncogene product in cellular transformation

Lucas Willems; Hubertine Heremans; Gao Chen; Daniel Portetelle; Alfons Billiau; Arsène Burny; Richard Kettmann

Human T‐lymphotropic viruses (HTLV‐I and ‐II) and bovine leukaemia virus (BLV) express transactivator proteins able to increase long terminal repeat (LTR) directed viral expression. These transacting factors are though to be involved in the induction of leukaemia by these viruses. Transfection of BLV transactivator p34tax together with Ha‐ras immortalizes and transforms rat embryo fibroblasts, in vitro. The transformed cell induce tumours in nude mice. These data emphasize the causal role exerted by p34tax in in vivo tumorigenesis.


Proceedings of the National Academy of Sciences of the United States of America | 2008

Protein phosphatase 2A controls the activity of histone deacetylase 7 during T cell apoptosis and angiogenesis.

Maud Martin; Michael Potente; Veerle Janssens; Didier Vertommen; Jean-Claude Twizere; Mark H. Rider; Jozef Goris; Stefanie Dimmeler; Richard Kettmann; Franck Dequiedt

Class IIa histone deacetylases (HDACs) act as key transcriptional regulators in several important developmental programs. Their activities are controlled via phosphorylation-dependent nucleocytoplasmic shuttling. Phosphorylation of conserved serine residues triggers association with 14-3-3 proteins and cytoplasmic relocalization of class IIa HDACs, which leads to the derepression of their target genes. Although a lot of effort has been made toward the identification of the inactivating kinases that phosphorylate class IIa HDAC 14-3-3 motifs, the existence of an antagonistic protein phosphatase remains elusive. Here we identify PP2A as a phosphatase responsible for dephosphorylating the 14-3-3 binding sites in class IIa HDACs. Interestingly, dephosphorylation of class IIa HDACs by PP2A is prevented by competitive association of 14-3-3 proteins. Using both okadaic acid treatment and RNA interference, we demonstrate that PP2A constitutively dephosphorylates the class IIa member HDAC7 to control its biological functions as a regulator of T cell apoptosis and endothelial cell functions. This study unravels a dynamic interplay among 14-3-3s, protein kinases, and PP2A and provides a model for the regulation of class IIa HDACs.


The EMBO Journal | 1987

The bovine leukemia virus p34 is a transactivator protein

Lucas Willems; Anne Gegonne; Guangling Chen; Arsène Burny; Richard Kettmann; Jacques Ghysdael

Recombinant Moloney murine retroviruses containing the BLV post‐envelope long open reading frame were constructed and transfected into the psi 2 packaging cell line. They were shown to encode and to express a 34‐kd protein able to transactivate the BLV long terminal repeat‐directed gene expression in the respective transfected cells. These data demonstrate that the BLV X‐LOR gene encodes a p34 transactivator product. Furthermore, the different cell lines produced infectious recombinant retroviruses capable of transferring X‐LOR genes into recipient cells. The availability of the BLV transactivator protein should allow us to understand the role of the transactivator protein in BLV‐induced leukemogenesis.


AIDS Research and Human Retroviruses | 2000

Genetic Determinants of Bovine Leukemia Virus Pathogenesis

Luc Willems; Arsène Burny; Delphine Collete; O. Dangoisse; Franck Dequiedt; Jean-Stéphane Gatot; Pierre Kerkhofs; Laurent Lefèbvre; C. Merezak; T. Peremans; Daniel Portetelle; Jean-Claude Twizere; Richard Kettmann

The understanding of HTLV-induced disease is hampered by the lack of a suitable animal model allowing the study of both viral replication and leukemogenesis in vivo. Although valuable information has been obtained in different species, such as rabbits, mice, rats, and monkeys, none of these systems was able to conciliate topics as different as viral infectivity, propagation within the host, and generation of leukemic cells. An alternate strategy is based on the understanding of diseases induced by viruses closely related to HTLV-1, like bovine leukemia virus (BLV). Both viruses indeed belong to the same subfamily of retroviruses, harbor a similar genomic organization, and infect and transform cells of the hematopoietic system. The main advantage of the BLV system is that it allows direct experimentation in two different species, cattle and sheep.


Advances in Cancer Research | 1978

Bovine Leukemia Virus Involvement In Enzootic Bovine Leukosis

Arsène Burny; F. Bex; H. Chantrenng; Y. Cleuter; D. Dekegel; J. Ghysdael; Richard Kettmann; M. Leclercq; J. Leunen; Marc Mammerickx; Daniel Portetelle

Publisher Summary Enzootic bovine leukosis is a contagious disease induced by bovine leukemia virus (BLV). It is a chronic disease that develops over a long period and can be schematically divided into three phases: (1) from birth to infection (some animals are already infected at birth), (2) from viral infection to tumorous transformation (a number of infected animals do not develop tumors before being slaughtered), and (3) from tumorous transformation to death. Bovine leukotic lymphocytes, kept in vitro in suitable medium, release detectable amounts of BLV. Short-term cultures of leukocytes from cows with persistent lymphocyotsis or long-term cultures of BLV-infected cells were used to study the morphogenesis of BLV, wherein one system was made of degenerating cells, the other made of healthy fast growing cells. Detection of anti-BLV antibodies includes immunodiffusion using p 24 , p 15 , immunofluorescence (IF), complement fixation (CF), and radioimmunoassay. All these methods are indirect detection methods. They detect BLV infection through the immune reaction of the host. The chapter presents the experiments performed to understand the transmission of BLV to the homologous host.

Collaboration


Dive into the Richard Kettmann's collaboration.

Top Co-Authors

Avatar

Arsène Burny

Université libre de Bruxelles

View shared research outputs
Top Co-Authors

Avatar

Daniel Portetelle

Université libre de Bruxelles

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Yvette Cleuter

Université libre de Bruxelles

View shared research outputs
Top Co-Authors

Avatar

Marc Mammerickx

Université libre de Bruxelles

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

A. Burny

Institut Jules Bordet

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jacques Ghysdael

Université libre de Bruxelles

View shared research outputs
Researchain Logo
Decentralizing Knowledge